No Data
No Data
Stocks that moved the previous day part 2: Mitsubishi Logistics Next, G.C. Planning, Japan Rad, etc.
Stock name <code> Closing price on the 9th ⇒ Change from previous day ACCESS <4813> 909 -30 Continued caution regarding inappropriate revenue recognition. Trichemical Research Institute <4369> 2780 -106 Small and medium-sized semiconductor-related stocks are also sluggish due to the decline in semiconductor stocks. Mitsukoshi Isetan <3099> 2259 -66 The movement of expectations for china inbound has temporarily calmed down. SCREEN <7735> 9406 -259 Continued selling pressure on main semiconductor-related stocks. F&LC <3563> 3485 -6.
Digest of emerging markets stocks: yutori surged significantly, and Trase OP skyrocketed.
The initial price of Infomatis 1070 was set at 993 yen, which is 8.1% below the public offering price, with a trading volume of 0.3 million 5,700 shares at the time of initial pricing. After that, buyers were seen, bringing it closer to the public offering price. The company operates in the energy informatics sector, providing smart living services that analyze energy-related data using proprietary AI to achieve energy saving and comfortable living, and energy management services that optimize energy operation efficiency.
Renaissance - temporarily surged significantly, expected to secure profitability in the fiscal year ending March 2025.
A significant rise was observed at one point. After the trading ended last weekend, the financial estimates for the fiscal year ending in March 2025 were revised. The net profit is now estimated to be a surplus of 0.046 billion yen, changing from the previous estimate of a deficit of 0.091 billion yen. In the previous period, there was a deficit of 0.258 billion yen. This change is due to the special profit being recorded from the debt forgiveness related to the debt reduction (release of bank deposits as collateral), following the conclusion of the AMED's medical research and development innovation infrastructure creation project (CiCLE) in November 2024. However, the operating profit and loss remain at the previous estimate of 0.257 billion.
Strong performance, supported by the rise in nasdaq and the decline in U.S. long-term gold rates.
[Emerging markets individual stock strategy] Today, a solid development is expected in the emerging markets. Last weekend, on the 6th in the US stock market, the Dow Jones Industrial Average fell by 123.19 points (-0.28%) to 44,642.52 points, continuing the decline. Expectations for additional rate cuts at the December Federal Open Market Committee (FOMC) meeting increased after the employment statistics, but the Dow turned down due to the decline of managed healthcare company UnitedHealth (UNH). The NASDAQ, supported by early rate cut expectations, moved steadily throughout the day and reached its all-time high for several consecutive days.
Renascience [emerging markets press release]
Lena Science revises financial estimates, expecting an operating loss of -0.267 billion yen for this fiscal year compared to -0.257 billion yen.
Ain HD, 2Q operating profit decreased by 32.9% to 5.872 billion yen.
Ain HD (9627) announced its performance for the second quarter of the fiscal year ending April 2025, with revenue increasing by 10.9% year-on-year to 214.8 billion yen, and operating profit decreasing by 32.9% to 5.872 billion yen. The main pharmacy business saw an increase in the prescription of high-priced pharmaceuticals, leading to a rise in prescription unit prices. However, factors such as the impact of the June reimbursement revision for pharmacy fees affected the results. [Positive rating] Renascience (4889) revised | Kanamoto (9678) full year [Hold] (381)